An Open-label, Non-randomized, Pharmacokinetic and Safety Study of Single Dose Ensifentrine in Healthy Subjects and in Subjects with Moderate and Severe Hepatic Impairment

Principal Investigator

Richard Preston

Enrollment Status

Closed

Clinical Trial ID

Institutional Protocol # 20220003

Clinical Trial Summary

An Open-label, Non-randomized, Pharmacokinetic and Safety
Study of Single Dose Ensifentrine in Healthy Subjects and in
Subjects with Moderate and Severe Hepatic Impairment
Protocol Number: RPL554-PK-103

Phase

Phase I

Funding Agency/Sponsor

Industry

Disease

Other

Contact Information

Study Contact Olga Acosta

Phone Number +1 (305) 9844319

Email oacosta@miami.edu